NeoPharm CO., LTD. (092730.KQ)
KRW 12780.0
(-4.91%)
KRW 12780.0
(-4.91%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 64.15 Billion KRW | 12.0% |
| 2022 | 57.27 Billion KRW | -6.58% |
| 2021 | 61.31 Billion KRW | 6.57% |
| 2020 | 57.53 Billion KRW | -2.95% |
| 2019 | 59.28 Billion KRW | 23.59% |
| 2018 | 47.96 Billion KRW | 20.58% |
| 2017 | 39.77 Billion KRW | 26.39% |
| 2016 | 31.47 Billion KRW | 20.9% |
| 2015 | 26.03 Billion KRW | 0.0% |
| 2014 | 18.75 Billion KRW | N/A |
| 2013 | 15.06 Billion KRW | N/A |
| 2012 | 14.08 Billion KRW | 0.0% |
| 2011 | 12.5 Billion KRW | N/A |
| 2010 | 11.39 Billion KRW | N/A |
| 2009 | 11.69 Billion KRW | N/A |
| 2008 | 9.93 Billion KRW | N/A |
| 2007 | 4.61 Billion KRW | N/A |
| 2006 | 9.09 Billion KRW | N/A |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 16.85 Billion KRW | -1.64% |
| 2024 Q3 | 26.15 Billion KRW | -4.5% |
| 2024 Q2 | 16.73 Billion KRW | -0.73% |
| 2023 Q1 | 16.02 Billion KRW | 6.8% |
| 2023 Q4 | 17.13 Billion KRW | 18.81% |
| 2023 FY | 64.15 Billion KRW | 12.0% |
| 2023 Q2 | 16.56 Billion KRW | 3.34% |
| 2023 Q3 | 14.42 Billion KRW | -12.94% |
| 2022 Q2 | 14.25 Billion KRW | -6.69% |
| 2022 Q4 | 15 Billion KRW | 18.32% |
| 2022 FY | 57.27 Billion KRW | -6.58% |
| 2022 Q3 | 12.68 Billion KRW | -11.03% |
| 2022 Q1 | 15.27 Billion KRW | -9.58% |
| 2021 Q4 | 16.89 Billion KRW | 27.57% |
| 2021 Q3 | 13.24 Billion KRW | -12.4% |
| 2021 FY | 61.31 Billion KRW | 6.57% |
| 2021 Q2 | 15.12 Billion KRW | -5.77% |
| 2021 Q1 | 16.04 Billion KRW | -2.42% |
| 2020 Q2 | 15.27 Billion KRW | 6.7% |
| 2020 FY | 57.53 Billion KRW | -2.95% |
| 2020 Q4 | 16.44 Billion KRW | 30.37% |
| 2020 Q1 | 14.31 Billion KRW | -13.53% |
| 2020 Q3 | 12.61 Billion KRW | -17.4% |
| 2019 FY | 59.28 Billion KRW | 23.59% |
| 2019 Q4 | 16.55 Billion KRW | 20.85% |
| 2019 Q1 | 14.66 Billion KRW | 7.03% |
| 2019 Q2 | 15.18 Billion KRW | 3.55% |
| 2019 Q3 | 13.69 Billion KRW | -9.82% |
| 2018 Q1 | 12.6 Billion KRW | 4.29% |
| 2018 FY | 47.96 Billion KRW | 20.58% |
| 2018 Q3 | 10.64 Billion KRW | -6.55% |
| 2018 Q2 | 11.38 Billion KRW | -9.66% |
| 2018 Q4 | 13.7 Billion KRW | 28.79% |
| 2017 Q1 | 10.09 Billion KRW | 5.92% |
| 2017 FY | 39.77 Billion KRW | 26.39% |
| 2017 Q2 | 9.61 Billion KRW | -4.78% |
| 2017 Q3 | 8.35 Billion KRW | -13.08% |
| 2017 Q4 | 12.08 Billion KRW | 44.68% |
| 2016 Q3 | 6.18 Billion KRW | -8.55% |
| 2016 FY | 31.47 Billion KRW | 20.9% |
| 2016 Q2 | 6.76 Billion KRW | -27.94% |
| 2016 Q4 | 9.52 Billion KRW | 53.98% |
| 2016 Q1 | 9.39 Billion KRW | -2.5% |
| 2015 Q2 | 4.88 Billion KRW | 0.0% |
| 2015 FY | 26.03 Billion KRW | 0.0% |
| 2015 Q3 | 5.13 Billion KRW | 5.3% |
| 2015 Q4 | 9.63 Billion KRW | 87.41% |
| 2013 Q2 | 3.22 Billion KRW | -25.2% |
| 2013 Q1 | 4.3 Billion KRW | -2.83% |
| 2013 Q3 | 2.3 Billion KRW | -28.46% |
| 2012 Q4 | 4.43 Billion KRW | 0.0% |
| 2012 FY | 14.08 Billion KRW | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Kolmar BNH Co., Ltd. | 78.39 Billion KRW | 18.17% |